Mucosal immunization with a measles virus CTL epitope encapsulated in biodegradable PLG microparticles.
The immunogenicity of a cytotoxic T cell epitope (CTL) representing residues 52-60 from measles virus (MV) nucleoprotein, encapsulated in poly(lactide-co-glycolide) (PLG) microparticles was evaluated after mucosal immunization. After intranasal administration of the encapsulated CTL epitope linked at the carboxyl terminus of two copies of a T-helper epitope (TT-NP6), peptide-specific and MV-specific CTL responses were detected in splenocytes. However, these responses were lower than the responses observed when the TT-NP6 peptide was administered intranasally in saline or using CTB as an adjuvant. Intranasal coadministration of the encapsulated TT-NP6 peptide with CTB did not result in any significant potentiation of the CTL responses. The effectiveness of biodegradable PLG microparticles for mucosal delivery of CTL epitopes, combined with their excellent tissue compatibility and biodegradability suggests that they represent a valuable delivery system for synthetic immunogens. However, further work is needed to define the requirements for effective absorption by the nasal epithelium.
Partidos
C D
CD
Department of Clinical Sciences, London School of Hygiene and Tropical Medicine, UK.
Vohra
P
P
Jones
D H
DH
Farrar
G H
GH
Steward
M W
MW
D000818:Animals; D000956:Antigens, Viral / Q000008:administration & dosage*; D007114:Immunization; D008459:Measles virus / Q000276:immunology*; D051379:Mice; D008808:Mice, Inbred CBA; D008863:Microspheres; D010446:Peptide Fragments / Q000008:administration & dosage; D011098:Polyglactin 910; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014764:Viral Proteins / Q000008:administration & dosage
D000956:Antigens, Viral; D010446:Peptide Fragments; D014764:Viral Proteins; D011098:Polyglactin 910